Markus Thor (MBA, MSc)
Background
2009- CEO & Senior Consultant at Thor Life Science Consulting AB
2009-2013 Chief Business Officer at Kancera AB (publ) and iNovacia AB
2006-2009 Vice President & Head, Business Development at Biovitrum AB (publ)
2003-2006 Director, Business Development at Biovitrum AB
2001-2003 Senior Scientist, R&D at Biovitrum AB
1994-2001 Medicinal Chemistry, R&D at Pharmacia Corp, Pharmacia & Upjohn Inc. and Pharmacia AB
Education
- Executive MBA from Stockholm School of Economics
- Certified Board Director at The Swedish Academy of Board Directors
- MSc (Chemistry) from University of Umeå
Experience from a wide range of deal types:
- In-licensing
- Out-licensing
- FTO licenses
- Mergers & Acquisitions
- Co-development
- Co-promotion
- Research collaborations
- Option agreements
- Service agreements
- Etc.
Experienced with term sheet and contract negotiations with wide range of countries and cultures and have closed deals in USA, Europe and Asia.
Experience from a range of therapeutic areas:
- Cancer
- Ophthalmology
- Metabolic diseases
- Inflammation
- Pain
- Infectious disease
- Etc.
Experience from a range of technologies:
- Small molecules
- Biologics
- Vaccines
- Nanotechnology
- Diagnostics